States have to turn that information into medical frailty determinations that are clinically credible, consistent, and workable across large Medicaid populations.
|Slideshows|September 23, 2018
Health Execs Share Their Favorite Interview Questions
Author(s)Tracey Walker
Managed Healthcare Executive asked healthcare executives about their interview techniques, how they approach job interviews, and the one doozy of a question that they like to ask job candidates. Here’s what they said.
Advertisement
Managed Healthcare Executive asked healthcare executives about their interview techniques, how they approach job interviews, and the one doozy of a question that they like to ask job candidates. Here’s what they said.
Advertisement
Related to this article
A meta-analysis found steatotic liver disease in 75% of patients with sleep-disordered breathing and that CPAP lowered liver enzymes but not liver fat.
Some predicted that drugmakers might boost launch prices to make up for Medicare drug negotiations shrinking profits. Harvard researchers find no evidence of that happening so far.
State PBM reform accelerates through 2026, with Theresa Carnegie of Mintz unpacking new laws, rebate pass-through, spread pricing bans, and compliance risks.
Only 19.1% of commercially insured patients with first-episode psychosis were adherent to antipsychotics in the year after starting treatment.
Prioritizing referral completion as much as referral generation will equip organizations to measure results and improve health outcomes.
Daiichi Sankyo and Merck pulled their bid for accelerated approval of I-DXd in small cell lung cancer after the FDA found phase 2 data fell short.
In this discussion, Chad Hatfield, Pharm.D., M.H.A., BCPS, shares his perspective on the evolving role of pharmacy services and the value of collaboration across health care.
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Tariffs on patented drugs now apply to all branded drugmakers
2
A head-to-head phase 3b comparison of bimekizumab with risankizumab in active psoriatic arthritis: Written recap
3
Fewer than 1 in 5 young patients with first-episode psychosis adhere to antipsychotics
4
When the referral isn't the finish line: Making SDOH programs actually close care gaps
5